Fenofibrate is a prescription medication used to lower high triglycerides and treat abnormal cholesterol levels. It belongs to a class of drugs called fibrates and is taken as a once-daily pill. Its primary role today is managing severely elevated triglycerides, particularly when levels climb high enough to risk dangerous inflammation of the pancreas.
The Two Main Uses
Fenofibrate is prescribed for two related but distinct lipid problems. The first, and most important in current practice, is severe hypertriglyceridemia, meaning triglyceride levels at or above 500 mg/dL. At these levels, fat particles in the blood can trigger acute pancreatitis, a painful and potentially life-threatening condition. The 2026 ACC/AHA guidelines identify fenofibrate as a first-line option for severe hypertriglyceridemia, especially when triglycerides reach 1,000 mg/dL or higher.
The second use is mixed dyslipidemia, a combination of high LDL (“bad”) cholesterol and elevated triglycerides that often comes with low HDL (“good”) cholesterol. In this situation, fenofibrate may be added alongside diet changes to improve the overall lipid picture.
How Well It Works
Fenofibrate’s strongest effect is on triglycerides. In FDA registration trials, patients with moderately high triglycerides (150 mg/dL and above) saw an average 36% drop in triglyceride levels over three to six months. For people with severe hypertriglyceridemia, the reductions were even more dramatic: patients starting between 350 and 499 mg/dL experienced a 46% decrease, and those starting between 500 and 1,500 mg/dL saw triglycerides fall by about 55%.
The drug also raises HDL cholesterol. Across clinical trials, HDL increased by roughly 11% on average, and by 20 to 23% in patients with severe hypertriglyceridemia. These shifts matter because low HDL is an independent risk factor for heart disease.
What Fenofibrate Does Not Do
One important distinction: fenofibrate has not been shown to reduce heart attacks or strokes when added to statin therapy. Large cardiovascular outcomes trials, including those in patients with diabetes, found no additional benefit for preventing cardiovascular events when fenofibrate was used on top of a statin. Current guidelines explicitly state that fibrates are not recommended for routine use as add-on therapy to statins for heart disease prevention. This is a meaningful difference from statins themselves, which have strong evidence for reducing cardiovascular events. Fenofibrate’s value lies specifically in lowering dangerously high triglycerides and the pancreatitis risk that comes with them.
How It Works in the Body
Fenofibrate activates a receptor inside cells called PPAR-alpha, which acts like a switch for genes involved in fat metabolism. When this switch is turned on, two key things happen. First, your body produces more of an enzyme that breaks down triglyceride-rich particles in the blood, clearing them faster. Second, it dials down production of a protein that normally slows triglyceride clearance. The combined effect is a significant drop in circulating triglycerides.
For HDL, the mechanism is different. Fenofibrate ramps up production of apoA-I, the main structural protein in HDL particles. More apoA-I means more HDL assembled and released into the bloodstream.
How You Take It
Fenofibrate comes in both tablets and capsules, taken once daily. The exact dose depends on which formulation you’re prescribed. Some versions (sold under names like Tricor and Triglide) can be taken with or without food, while others (like Lipofen and Lofibra) need to be taken with a meal for proper absorption. For triglyceride lowering, doctors often start at a lower dose and adjust upward based on your lab results. For cholesterol management, the full dose is typically used from the start.
Consistency matters with this medication. Taking it at the same time each day helps maintain steady levels in your system.
Who Should Not Take Fenofibrate
Fenofibrate is not safe for everyone. It is contraindicated in people with severe kidney impairment, including those on dialysis. For people with mild to moderate kidney problems, a lower starting dose is used, with kidney function monitored before any increase. Active liver disease also rules out fenofibrate, as the drug is processed through the liver and can worsen existing liver damage. People with pre-existing gallbladder disease should avoid it as well, since fibrates increase cholesterol content in bile and can promote gallstone formation.
Using Fenofibrate With a Statin
Many people with high triglycerides are already taking a statin for cholesterol. Adding fenofibrate to a statin is sometimes necessary when triglycerides remain dangerously elevated despite statin therapy, diet changes, and addressing other contributing factors like uncontrolled diabetes or alcohol use. Fenofibrate is the preferred fibrate for this combination. Its cousin gemfibrozil interacts more aggressively with statins and raises the risk of muscle damage, so current guidelines specifically recommend fenofibrate over gemfibrozil when a fibrate needs to be paired with statin therapy.
Common Side Effects
Most people tolerate fenofibrate without major problems. The more common side effects include stomach discomfort, nausea, and headache. Liver enzyme elevations can occur, which is why periodic blood tests are standard during treatment. A rare but serious risk is muscle breakdown, known as rhabdomyolysis, which is more likely when fenofibrate is combined with a statin. Signs to watch for include unexplained muscle pain, tenderness, or weakness, especially if accompanied by dark-colored urine. Fenofibrate can also raise creatinine levels, a marker of kidney function, so kidney labs are typically monitored alongside lipid panels.